Don Debethizy

Don deBethizy is a seasoned professional in the biopharmaceutical industry, currently serving as a member of the Board of Directors for multiple companies, including Lophora ApS, argenx, Newron Pharmaceuticals SpA, and Proterris Inc. Since January 2021, Don has actively contributed to Lophora, a drug-development start-up focused on innovative treatments for central nervous system diseases. In addition, Don founded White City Consulting ApS in 2014, providing strategic advisory services to technology-focused companies. Notably, Don held the position of Chairman of the Board of Directors at Albumedix until October 2022 and has extensive experience with other organizations such as NOXXON Pharma N.V. and Rigontec GmbH, showcasing a strong commitment to advancing therapies for challenging medical conditions. Don received a Master's and Ph.D. in Toxicology from Utah State University and a Bachelor’s degree in Biology from the University of Maryland.